国产精品欧美日韩第5页-国产精品欧美日韩一二三四-国产精品欧美日韩一区二区-国产精品欧美视频另类专区-国产精品欧美亚洲-国产精品欧美亚洲韩国日

About Us

Tianjin Orilife Biopharma Co.,Ltd.

Tianjin Orilife Biopharma Co.,Ltd. is an enterprise engaged in the research, production, and sales of modified nucleosides, nucleotides, phosphoramidites, nucleic acid drug synthesis carriers, nucleic acid drug delivery carriers, and auxiliary materials for nucleic acid drug synthesis.

  • 50+

    Reaction Kettles

  • 6000kg

    Designed Production Capacity

  • 30Years

    Research and Development Experience

Chief Scientist Dr Zhang Peizhuo
Graduated from Tianjin University with a degree in chemical engineering, obtained a Ph.D. in Medicinal Chemistry from Beijing Medical University, previously worked at the New Drug Development Center of the National Medical Products Administration, awarded a Royal Scholarship to pursue postdoctoral research at King's College London, conducted RNA chemistry research under the guidance of the renowned nucleic acid chemist Professor C.B. Reese. Later held positions as a senior researcher and R&D department manager at the well-known nucleic acid chemical manufacturer Cruachem.
Application Area Orilife provides raw materials for the small nucleic acid drug industry, which has a rich pool of candidate targets, a wide range of indications, and great application potential.
Small nucleic acid drugs are pharmaceuticals composed of artificially chemically synthesized short ribonucleotides, either single-stranded or double-stranded. They act on messenger RNA through the Watson-Crick base pairing principle. Compared to traditional drugs, small nucleic acid drugs have significant advantages in candidate targets, design, specificity, efficacy, and clinical development success rate. Coupled with the maturity of RNAi technology, small nucleic acid drugs are expected to have extensive applications in the fields of oncology and rare diseases, potentially improving the accessibility of medications for rare disease patients.
Customized Product Factory visits are welcomed
We can provide custom synthesis of DNA/RNA monomers, accepting orders from milligram to kilogram quantities.
01 R&D Strength

02 Quality Control

03 Application Area

04 Customized Product

Development History

August 2020
Rianlon and GenePharma collaborate on the project of 'Small Nucleic Acid Drug Raw Materials'.
December 2020
Rianlon Life Sciences Division has been officially established.
13 April 2021
Tianjin Orilife Biopharma Co., Ltd. is established, and Rianlon collaborates with GenePharma to enter the field of small nucleic acid drug raw materials.
30 September 2022
Orilife's nucleic acid monomer pilot development project has passed the acceptance inspection.
December 2022
Orilife’s nucleic acid monomer trial production.
August 2020
December 2020
April 2021
September 2022
December 2022

NEWS

News

  • Company News
  • Industry News
  • Announcements
主站蜘蛛池模板： 成人啪精品视频免费网站 | 区三区免费 | 少妇内射高潮 | 亚洲天堂网一区二区三区四区 | 91久久精品国产91久久性色t | 成人无码视频在线播放 | 亚洲国产精品热久久 | 国产精品白丝av网站 | 午夜无码一区二区三区在线 | 一区二区三区 | 亚洲日韩视频精品一区 | 成人在线免费av视频 | 国产成人精品日本亚洲专一区 | 性色av无码一区二区三区人妻 | 91大神大战高跟丝袜美女 | 制服丝袜99在线不卡 | 亚洲欧美综合日韩字幕v在线 | 日本在线播放不卡一区二区视频 | 夜夜春亚洲嫩草影院 | 成人午夜高 | 婷婷色中文字幕综合在线 | 亚洲精品中国国产嫩草影院美女 | 午夜福利视频 | 欧美丶日韩丶国产丶另类 | 日韩免费在线观看国产一区二区三区 | 91香蕉视频黄色app下载 | 国产精品无码专区 | 午夜亚洲国产理论 | 国产精品亚洲综合色区韩国 | 亚洲第一成人网 | 国产成人久久久 | 精品亚洲国产成人蜜芽av小说 | 天天射天天操天天 | 国产清纯91天堂在线观看 | 最新剧情片大全免费在线观看 | 国产福利91精品在线观看 | 91视频精品 | 国产精品一区在线免费观看 | 蜜臀91精品国产免费观看 | 国产精品亚洲一区二区三区 | 婷婷综合另类小说色区 |